Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Thomas Shrader's Stock Ratings
BTIG Analyst
Thomas Shrader is an analyst at BTIG. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 04/19/2025
Overall Average Return
-13.4%
Smart Score
Overall Average Return Percentile
19th
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 04/07/2025 | ALDX | Buy Now | Aldeyra Therapeutics | $2.17 | 314.75% | Thomas Shrader40% | $11 → $9 | Maintains | Buy | Get Alert |
| 03/24/2025 | OVID | Buy Now | Ovid Therapeutics | $0.30 | 1242.28% | Thomas Shrader40% | $5 → $4 | Maintains | Buy | Get Alert |
| 02/24/2025 | PCVX | Buy Now | Vaxcyte | $30.41 | 426.14% | Thomas Shrader40% | $160 → $160 | Reiterates | Buy → Buy | Get Alert |
| 01/28/2025 | ARCT | Buy Now | Arcturus Therapeutics | $10.62 | 285.98% | Thomas Shrader40% | → $41 | Initiates | → Buy | Get Alert |
| 11/26/2024 | ALEC | Buy Now | Alector | $0.92 | 443.42% | Thomas Shrader40% | $16 → $5 | Maintains | Buy | Get Alert |
| 09/04/2024 | ATHA | Buy Now | Athira Pharma | $0.24 | — | Thomas Shrader40% | — | Downgrade | Buy → Neutral | Get Alert |
| 09/03/2024 | PCVX | Buy Now | Vaxcyte | $30.41 | 426.14% | Thomas Shrader40% | $98 → $160 | Maintains | Buy | Get Alert |
| 08/07/2024 | PCVX | Buy Now | Vaxcyte | $30.41 | 222.26% | Thomas Shrader40% | $98 → $98 | Reiterates | Buy → Buy | Get Alert |
| 06/18/2024 | OVID | Buy Now | Ovid Therapeutics | $0.30 | 1577.85% | Thomas Shrader40% | $11 → $5 | Maintains | Buy | Get Alert |
| 05/31/2024 | ACIU | Buy Now | AC Immune | $1.48 | 440.54% | Thomas Shrader40% | → $8 | Initiates | → Buy | Get Alert |
| 12/21/2023 | OVID | Buy Now | Ovid Therapeutics | $0.30 | 3591.28% | Thomas Shrader40% | → $11 | Initiates | → Buy | Get Alert |
| 10/03/2023 | PMN | Buy Now | ProMIS Neurosciences | $0.58 | 1286.48% | Thomas Shrader40% | → $8 | Initiates | → Buy | Get Alert |
| 07/28/2023 | DTIL | Buy Now | Precision BioSciences | $5.06 | -60.47% | Thomas Shrader40% | $180 → $60 | Maintains | Buy | Get Alert |
| 06/30/2023 | SGTX | Buy Now | Sigilon Therapeutics | — | — | Thomas Shrader40% | — | Downgrade | Buy → Neutral | Get Alert |
| 06/06/2023 | BHVN | Buy Now | Biohaven | $20.50 | 36.59% | Thomas Shrader40% | $24 → $24 | Reiterates | → Buy | Get Alert |
| 05/25/2023 | ANNX | Buy Now | Annexon | $1.46 | 379.45% | Thomas Shrader40% | $15 → $7 | Maintains | Buy | Get Alert |
| 05/18/2023 | COYA | Buy Now | Coya Therapeutics | $5.78 | 159.52% | Thomas Shrader40% | → $15 | Initiates | → Buy | Get Alert |
| 03/30/2023 | ATHA | Buy Now | Athira Pharma | $0.24 | 4084.1% | Thomas Shrader40% | $33 → $10 | Maintains | Buy | Get Alert |
| 03/28/2023 | BCAB | Buy Now | BioAtla | $0.32 | 3912.35% | Thomas Shrader40% | $68 → $13 | Maintains | Buy | Get Alert |
| 03/20/2023 | VRNA | Buy Now | Verona Pharma | $57.50 | -46.09% | Thomas Shrader40% | $26 → $31 | Maintains | Buy | Get Alert |
| 03/02/2023 | ALEC | Buy Now | Alector | $0.92 | 1638.94% | Thomas Shrader40% | $54 → $16 | Maintains | Buy | Get Alert |
| 12/20/2022 | VRNA | Buy Now | Verona Pharma | $57.50 | -54.78% | Thomas Shrader40% | $17 → $26 | Maintains | Buy | Get Alert |
| 12/02/2022 | BHVN | Buy Now | Biohaven | $20.50 | 17.07% | Thomas Shrader40% | → $24 | Initiates | → Buy | Get Alert |
| 11/17/2022 | PCVX | Buy Now | Vaxcyte | $30.41 | 126.9% | Thomas Shrader40% | → $69 | Initiates | → Buy | Get Alert |
| 11/14/2022 | GANX | Buy Now | Gain Therapeutics | $1.82 | 449.45% | Thomas Shrader40% | $30 → $10 | Maintains | Buy | Get Alert |
| 10/06/2022 | SQZ | Buy Now | SQZ Biotechnologies | — | — | Thomas Shrader40% | $400 → $150 | Maintains | Buy | Get Alert |
| 10/05/2022 | ABOS | Buy Now | Acumen Pharmaceuticals | $1.02 | 2056.86% | Thomas Shrader40% | $15 → $22 | Maintains | Buy | Get Alert |
| 09/09/2022 | ANNX | Buy Now | Annexon | $1.46 | 927.4% | Thomas Shrader40% | → $15 | Initiates | → Buy | Get Alert |
| 07/15/2022 | ABOS | Buy Now | Acumen Pharmaceuticals | $1.02 | 1370.59% | Thomas Shrader40% | → $15 | Initiates | → Buy | Get Alert |
| 05/24/2022 | INMB | Buy Now | INmune Bio | $7.32 | 91.26% | Thomas Shrader40% | $31 → $14 | Maintains | Buy | Get Alert |
| 05/10/2022 | ATHA | Buy Now | Athira Pharma | $0.24 | 13707.53% | Thomas Shrader40% | → $33 | Initiates | → Buy | Get Alert |
| 10/29/2021 | SGTX | Buy Now | Sigilon Therapeutics | — | — | Thomas Shrader40% | → $182 | Initiates | → Buy | Get Alert |
| 04/20/2021 | PLRX | Buy Now | Pliant Therapeutics | $1.46 | 3393.15% | Thomas Shrader40% | → $51 | Initiates | → Buy | Get Alert |
| 04/12/2021 | GANX | Buy Now | Gain Therapeutics | $1.82 | 1548.35% | Thomas Shrader40% | → $30 | Initiates | → Buy | Get Alert |
| 03/26/2021 | BCAB | Buy Now | BioAtla | $0.32 | 26751.85% | Thomas Shrader40% | $47 → $87 | Maintains | Buy | Get Alert |
| 03/26/2021 | GXGX | Buy Now | GX Acquisition | — | — | Thomas Shrader40% | → $16 | Initiates | → Buy | Get Alert |
| 03/08/2021 | ONCS | Buy Now | OncoSec Medical | — | — | Thomas Shrader40% | → $220 | Initiates | → Buy | Get Alert |
| 03/08/2021 | NUVB | Buy Now | Nuvation Bio | $1.91 | 737.7% | Thomas Shrader40% | → $16 | Initiates | → Buy | Get Alert |
| 02/03/2021 | VYGR | Buy Now | Voyager Therapeutics | $3.16 | — | Thomas Shrader40% | — | Downgrade | Buy → Neutral | Get Alert |
| 01/11/2021 | BCAB | Buy Now | BioAtla | $0.32 | 14406.17% | Thomas Shrader40% | → $47 | Initiates | → Buy | Get Alert |
| 11/24/2020 | SQZ | Buy Now | SQZ Biotechnologies | — | — | Thomas Shrader40% | → $400 | Initiates | → Buy | Get Alert |
| 11/18/2020 | EIDX | Buy Now | Eidos Therapeutics | — | — | Thomas Shrader40% | — | Downgrade | Buy → Neutral | Get Alert |
| 10/16/2020 | DNLI | Buy Now | Denali Therapeutics | $12.74 | — | Thomas Shrader40% | — | Downgrade | Buy → Neutral | Get Alert |
| 09/23/2020 | VCNX | Buy Now | Vaccinex | $0.74 | — | Thomas Shrader40% | — | Downgrade | Buy → Neutral | Get Alert |
| 09/15/2020 | ETNB | Buy Now | 89bio | $6.12 | 847.71% | Thomas Shrader40% | $51 → $58 | Maintains | Buy | Get Alert |
| 09/01/2020 | INMB | Buy Now | INmune Bio | $7.32 | 214.21% | Thomas Shrader40% | → $23 | Initiates | → Buy | Get Alert |
| 09/01/2020 | CMPI | Buy Now | Checkmate Pharmaceuticals | — | — | Thomas Shrader40% | → $29 | Initiates | → Buy | Get Alert |
| 04/03/2020 | GERN | Buy Now | Geron | $1.28 | 134.38% | Thomas Shrader40% | $4 → $3 | Maintains | Buy | Get Alert |
| 08/09/2019 | DNLI | Buy Now | Denali Therapeutics | $12.74 | 135.48% | Thomas Shrader40% | → $30 | Initiates | → Buy | Get Alert |
| 08/02/2019 | ACOR | Buy Now | Acorda Therapeutics | — | — | Thomas Shrader40% | $1440 → $840 | Maintains | Hold | Get Alert |
| 04/18/2019 | EIDX | Buy Now | Eidos Therapeutics | — | — | Thomas Shrader40% | → $38 | Initiates | → Buy | Get Alert |
| 02/21/2019 | BIIB | Buy Now | Biogen | $118.61 | 191.71% | Thomas Shrader40% | $397 → $346 | Downgrade | Buy → Hold | Get Alert |
| 02/13/2019 | GERN | Buy Now | Geron | $1.28 | 212.5% | Thomas Shrader40% | → $4 | Initiates | → Buy | Get Alert |
| 08/07/2018 | ACOR | Buy Now | Acorda Therapeutics | — | — | Thomas Shrader40% | $1800 → $3000 | Maintains | Hold | Get Alert |
| 08/07/2018 | BIIB | Buy Now | Biogen | $118.61 | 232.18% | Thomas Shrader40% | → $394 | Reinstates | → Buy | Get Alert |
| 02/22/2018 | MNTA | Buy Now | Momenta Pharmaceuticals | — | — | Thomas Shrader40% | — | Upgrade | Hold → Buy | Get Alert |
| 11/16/2017 | ACOR | Buy Now | Acorda Therapeutics | — | — | Thomas Shrader40% | — | Downgrade | Buy → Hold | Get Alert |
| 10/27/2017 | Q | Buy Now | Quintiles IMS Holdings | — | — | Thomas Shrader40% | — | Upgrade | Hold → Buy | Get Alert |
| 10/17/2017 | BIIB | Buy Now | Biogen | $118.61 | — | Thomas Shrader40% | — | Upgrade | Hold → Buy | Get Alert |
| 10/05/2017 | MNTA | Buy Now | Momenta Pharmaceuticals | — | — | Thomas Shrader40% | — | Downgrade | Buy → Hold | Get Alert |
| 10/04/2017 | MNTA | Buy Now | Momenta Pharmaceuticals | — | — | Thomas Shrader40% | — | Downgrade | Buy → Hold | Get Alert |
| 06/30/2017 | WINT | Buy Now | Windtree Therapeutics | $1.12 | — | Thomas Shrader40% | — | Downgrade | Buy → Hold | Get Alert |
| 05/22/2017 | VRNA | Buy Now | Verona Pharma | $57.50 | -61.74% | Thomas Shrader40% | → $22 | Initiates | → Buy | Get Alert |
| 05/08/2017 | TOCA | Buy Now | Tocagen | — | — | Thomas Shrader40% | — | Initiates | → Buy | Get Alert |
| 03/03/2017 | KITE | Buy Now | Kite Pharma | — | — | Thomas Shrader40% | — | Downgrade | Buy → Hold | Get Alert |
| 08/19/2016 | GERN | Buy Now | Geron | $1.28 | — | Thomas Shrader40% | — | Initiates | → Neutral | Get Alert |
| 03/04/2016 | GI | Buy Now | EndoChoice Holdings | — | — | Thomas Shrader40% | $16 → $10 | Maintains | Buy | Get Alert |
| 03/04/2016 | ARMH | Buy Now | ARM Holdings | $44.02 | — | Thomas Shrader40% | — | Downgrade | Buy → Hold | Get Alert |
| 03/04/2016 | VTAE | Buy Now | Vitae Pharmaceuticals | — | — | Thomas Shrader40% | — | Downgrade | Buy → Hold | Get Alert |
